Antimutagenic effect of genistein

Czech Journal of Food Sciences

Volumn 24, Issue 3, 2006, Pages 119-126

  Polívková, Zdeňka ^a   Langová, Martina ^a   Šmerák, Petr ^a   Bártová, Jiřina ^a   Bárta, Ivo ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

2 amino 3 methylimidazo 4,5 f quinoline; Aflatoxin B1; Ames test; Chemoprevention; Micronucleus test; N nitroso N methylurea

Indexed keywords

BACTERIA (MICROORGANISMS); GLYCINE MAX; SALMONELLA TYPHIMURIUM;

EID: 33745726005     PISSN: 12121800     EISSN: None     Source Type: Journal    
DOI: 10.17221/3306-cjfs     Document Type: Article

References (32)

1. ADLERCREUTZ H., HONJO H., HIGASHI A., FOTSIS T., HAMALAINEN E., HASEGAWA T., OKADA H. (1991): Urinary excretion of lignins and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional diet. American Journal of Clinical Nutrition, 54: 1093-1100.
2. AMES B.N. (1971): The detection of chemical mutagens with enteric bacteria. In: HOLLAENDER A. (ed.): Chemical Mutagens. Principle and Methods for their Detection 1. Plenum, New York: 267-282.
3. AMES B.N., MCCANN J., YAMASAKI E. (1975): Methods for detection of carcinogens and mutagens with Salmonella/mammalian-microsome mutagenicity test. Mutation Research, 31: 347-364.
4. BOOS G., STOPPER H. (2000): Genotoxicity of several clinically used topoisomerase II inhibitors. Toxicology Letters, 116: 7-16.
5. BOUKER K.B., HILAKIVI-CLARKE L. (2000): Genistein: Does it prevent or promote breast cancer? Environmental Health Perspectives, 108: 701-708.
6. ČERNÁ M., DOBIÁŠ L., HÁJEK V. (1989): Amesova metoda. V. Metody biologického monitorování genotoxických účinků faktorů prostředi - Standardní metodika. Acta Hygienica, Epidemiologica et Microbiologica, 20: 33-56.
7. WAF1/CIP1, reduction of cyclin B1 and G2/M arrest by isoflavone genistein in human prostate carcinoma cells. Japanese Journal of Cancer Research, 91: 164-173.
8. CHOI Y.H., ZHANG L., LEE W.H., PARK K. (1998b): Genistein-induced G2/M arrest is associated with the inhbition of cyclin B1 and the induction of p21 in human breast carcinoma cells. International Journal of Oncology, 13: 391-396.
9. CORNWELL T., COHICK W., RASKIN I. (2004): Dietary phytoestrogens and health. Phytochemistry, 65: 995-1016.
10. DINGLEY K.H., UBICK E.A., CHIARAPPA-ZUCCA M.L., NOWELL S., ABEL S., EBELER S.E., MITCHELL A.E., BURNS S.A., STEINBERG F.M., CLIFFORD A.J. (2003): Effect of dietary constituents with chemopreventive potential on adduct formation of a low dose of the heterocyclic amines PhIP and IQ and phase II hepatic enzymes. Nutrition and Cancer, 46: 212-221.
11. DIXON R.A., FERREIRA D. (2002): Molecules of interest: genistein. Phytochemistry, 60: 205-211.
12. GOODMAN M.T., WILKENS L.R., HANKIN J.H., HYU L.C., WU A.H., KOLONEL L.N. (1997): Association of soy and fiber consumption with the risk of endometrial cancer. American Journal of Epidemiology, 146: 294-306.
13. HERBERT J., HURLEY T., OLENDZKI B., TEAS J., YUNSHENG M. et al. (1998): Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. Journal of National Cancer Institute, 90: 1637-1647.
14. KUMI-KIAKA J., SANDERSON N.A., HALL A. (2000): The mediating role of caspase-3 protease in the intracellular mechanism of genistein-induced apoptosis in human prostatic carcinoma cell lines, DU145 and LNCaP. Biological Cell, 92: 595-604.
15. LAMARTINIERE C.A., COTRONEO M.S., FRITZ W.A., WANG J., MENTOR-MARCEL R., ELGAVISH A. (2002): Genistein chemoprevention: Timing and mechanisms of action in murine mammary and prostate. Journal of Nutrition (Suppl.), 132: 552S-558S.
16. LEE H.P., GOURLEY L., DUFFY S.W., ESTEVE J., LEE J., DAY N.E. (1991): Dietary effects on breast cancer risk in Singapore. Lancet, 336: 1197-1200.
17. MARON D.M., AMES B.N. (1983): Revised methods for the Salmonella mutagenicity tests. Mutation Research, 113: 173-215.
18. MESSINA M.J., LOPRINZI CH.L. (2001): Soy for breast cancer survivors: A critical review of the literature. Journal of Nutrition (Suppl.), 132: 3095S-3108S.
19. MISRA R.R., HURSTING S.D., PERKINS S.N., SATHYA-MOORTHY N., MIRSALIS J.C., RICCIO E.S., CROWELL J.A. (2002): Genotoxicity and carcinogenicity studies of soy isoflavones. International Journal of Toxicology, 21: 277-285.
20. MIYAZAWA M., SAKANO K., NAKAMURA S., KOSAKA H. (1999): Antimutagenic activity of isoflavones from soybean seeds (Glycine max merrill). Journal of Agricultural and Food Chemistry, 47: 13456-1349.
21. PARK O.J., SURH Y.J. (2004): Chemoprotective potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicology Letters, 150: 43-56.
22. POLKOWSKI K., MAZUREK A.P. (2000): Biological properties of genistein. Review of an in vitro and in vivo data. Acta Poloniae Pharmaceutica - Drug Research, 57: 135-155.
23. ROSENBERG ZAND R.S., JENKINS D.J.A., DIAMANDIS E.P. (2002): Flavonoids and steroid hormone-dependent cancers. Journal of Chromatography B, 777: 219-232.
24. SARKAR F.H., LI Y. (2002): Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer and Metastasis Reviews, 21: 265-280.
25. SARKAR F.H., LI Y. (2004): Cell signaling pathways altered by natural chemopreventive agents. Mutation Research, 555: 53-64.
26. SCHMID W. (1975): The micronucleus test. Mutation Research, 31: 9-15.
27. SNYDER R.D., GILLIES P.J. (2002): Evaluation of clastogenic, DNA intercalative and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells. Environmental and Molecular Mutagenesis, 40: 266-276.
28. STOPPER H., SCHMITT E., KOBRAS K. (2005): Genotoxicity of phytoestrogens. Mutation Research, 574: 139-155.
29. TSUTSUI T., TAMURA Y., YAGI E., SOMEY A.H., HORI I., METZLER M., BARRET J.C. (2003): Cell-transforming activity and mutagenicity of 5 phytoestrogens in cultured mammalian cells. International Journal of Cancer, 105: 312-320.
30. WEISBURGER J.H., DOLAN L., PITTMAN B. (1998): Inhibition of PhIP mutagenicity by caffeine, lycopene, daizien and genistein. Mutation Research, 416: 125-128.
31. ZHENG W., DAI Q., CUSTER L., SHU X.O., WEN W.Q., JIN F., FRANKE A.A. (1999): Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiology Biomarkers & Prevention, 8: 35-40.
32. ZIEGLER R.G., HOOVER R.N., PIKE M.C., HILDESHEIM A., NOMURA A.M., WEST D.W., WU-WILLIAMS A.H., KOLONEL L.N., HORN-ROSS P.L., ROSENTHA J.F. et al. (1993): Migration patterns and breast cancer risk in Asian-American women. Journal of National Cancer Institute, 85: 1819-1827.